Cerity Partners’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,419
Closed -$25.7K 2750
2025
Q1
$25.7K Buy
+10,419
New +$24.8K ﹤0.01% 2437

Other funds holding SLRN

Cerity Partners's SLRN Position: Q2 2025 in Review

Cerity Partners sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 10,419 shares — an estimated $25.7K sold.

Cerity Partners first reported a position in SLRN in Q1 2025 and held it in 1 quarter. The position peaked at $25.7K in Q1 2025. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

  • Cerity Partners reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
  • Cerity Partners sold 10,419 ACELYRIN shares in Q2 2025, an estimated $25.7K.
  • Cerity Partners first reported a position in ACELYRIN in Q1 2025 and held it in 1 quarter.
  • Cerity Partners's ACELYRIN position peaked at $25.7K in Q1 2025.
  • 2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Cerity Partners's 13F filing for Q2 2025, filed 13 Aug 2025.